Evidence map›Paper›PMID 22226248›Full record

Trial reportJournal of diabetes science and technology2011

A controlled study of the effectiveness of an adaptive closed-loop algorithm to minimize corticosteroid-induced stress hyperglycemia in type 1 diabetes.

Joseph El Youssef, Jessica R Castle, Deborah L Branigan, Ryan G Massoud, Matthew E Breen, Peter G Jacobs, B Wayne Bequette, W Kenneth Ward

Registry-linked trialOpen access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in Journal of diabetes science and technology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01552603 (Sensor-controlled Insulin- and Glucagon Delivery in Subjects With Type 1 Diabetes), which is not on this map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01552603 phase2completednot on this mapstarted 2012, after this paper: background citation

Sensor-controlled Insulin- and Glucagon Delivery in Subjects With Type 1 Diabetes: Testing of an Automated System in a Supervised Inpatient Setting

TypeinterventionalSponsorLegacy Health SystemRan2012 to 2013Enrolled14ConditionsType I Diabetes MellitusArmsArtificial Pancreas Control Software
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Joseph El YoussefOregon Health & Science University, Portland, Oregon, USA.
Jessica R Castle
Deborah L Branigan
Ryan G Massoud
Matthew E Breen
Peter G Jacobs
B Wayne Bequette
W Kenneth Ward
Legacy Health · USOregon Health & Science University · USJacobs (United States) · USRensselaer Polytechnic Institute · US

Funding

TRAINING IN ENDOCRINOLOGY, DIABETES, NUTRITIONT32DK007674 · NIDDK · OREGON HEALTH & SCIENCE UNIVERSITY · PI KLEIN, ROBERT FREDERICK · 1993 to 2013
$3.1M
Optimization of an Adaptive Dual-Hormone External Endocrine Pancreas.K23DK090133 · NIDDK · OREGON HEALTH & SCIENCE UNIVERSITY · PI EL YOUSSEF, JOSEPH · 2011 to 2015
$863k
NIDDK NIH HHS K23 DK090133NIDDK NIH HHS T32 DK007674
6 · The paper itself

Abstract

To be effective in type 1 diabetes, algorithms must be able to limit hyperglycemic excursions resulting from medical and emotional stress. We tested an algorithm that estimates insulin sensitivity at regular intervals and continually adjusts gain factors of a fading memory proportional-derivative (FMPD) algorithm. In order to assess whether the algorithm could appropriately adapt and limit the degree of hyperglycemia, we administered oral hydrocortisone repeatedly to create insulin resistance. We compared this indirect adaptive proportional-derivative (APD) algorithm to the FMPD algorithm, which used fixed gain parameters. Each subject with type 1 diabetes (n = 14) was studied on two occasions, each for 33 h. The APD algorithm consistently identified a fall in insulin sensitivity after hydrocortisone. The gain factors and insulin infusion rates were appropriately increased, leading to satisfactory glycemic control after adaptation (premeal glucose on day 2, 148 ± 6 mg/dl). After sufficient time was allowed for adaptation, the late postprandial glucose increment was significantly lower than when measured shortly after the onset of the steroid effect. In addition, during the controlled comparison, glycemia was significantly lower with the APD algorithm than with the FMPD algorithm. No increase in hypoglycemic frequency was found in the APD-only arm. An afferent system of duplicate amperometric sensors demonstrated a high degree of accuracy; the mean absolute relative difference of the sensor used to control the algorithm was 9.6 ± 0.5%. We conclude that an adaptive algorithm that frequently estimates insulin sensitivity and adjusts gain factors is capable of minimizing corticosteroid-induced stress hyperglycemia.

Indexed as

AlgorithmsAdrenal Cortex HormonesAdultAgedBlood GlucoseDiabetes Mellitus, Type 1FemaleHumansHydrocortisoneHyperglycemiaHypoglycemic AgentsInsulinInsulin Infusion SystemsMaleMiddle AgedSensitivity and SpecificityAdrenal Cortex HormonesBlood GlucoseHydrocortisoneHypoglycemic AgentsInsulin

Identifiers

PMID22226248
PMCPMC3262697
OpenAlexW2007814859

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.